Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials - Tang, H L; Li, D D; Zhang, J J (Diabetes Obes Metab, 2016)